El Farmaceutica India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.63 M
as on 24-10-2024
About El Farmaceutica India
The Corporate was formerly known as Essatto Life Sciences India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.63 M.
Vatika Grover, Dilip Kumar, Om Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U74110DL2016PTC307369
- Company No.
307369
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does El Farmaceutica India Private Limited offer?
El Farmaceutica India Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Multivitamin Supplements, Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at El Farmaceutica India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vatika Grover  | Additional Director | 01-Nov-2018 | Current |
| Dilip Kumar | Director | 20-Oct-2016 | Current |
| Om Singh | Additional Director | 08-Apr-2024 | Current |
| Saurabh Kumar | Additional Director | 08-Apr-2024 | Current |
Financial Performance of El Farmaceutica India.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of El Farmaceutica India?
Unlock access to El Farmaceutica India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ashtaka Ingredients Private LimitedActive 1 month 10 daysVatika Grover, Dilip Kumar and 2 more are mutual person
- Devsevit Ayurveda Private LimitedActive 11 years 7 months
Vatika Grover, Dilip Kumar and 2 more are mutual person
- Bodhi's Hill Eco Resorts Private LimitedActive 4 years
Vatika Grover and Dilip Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 May 2023 | ₹4.63 M | Open |
How Many Employees Work at El Farmaceutica India?
Unlock and access historical data on people associated with El Farmaceutica India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of El Farmaceutica India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped El Farmaceutica India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
